Day: May 13, 2022

PHOENIX, May 13, 2022 (GLOBE NEWSWIRE) — QuoteMedia, Inc. (OTCQB: QMCI), a leading provider of market data and financial applications, announced financial results for the quarter ended March 31, 2022. QuoteMedia provides banks, brokerage firms, private equity firms, financial planners and sophisticated investors with a more economical, higher quality alternative source of stock market data and related research information. We compete with several larger legacy organizations and a modest community of other smaller companies. QuoteMedia provides comprehensive market data services, including streaming data feeds, on-demand request-based data (XML/JSON), web content solutions (financial content for website integration) and applications such as Quotestream Professional desktop and mobile.  Highlights for Q1 2022 include the following:Quarterly...

Conference call scheduled for 8:30 a.m. ET today MIAMI, May 13, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today provided a business update and reported its financial results for the first quarter ended March 31, 2022. First Quarter Business Updates: Lomecel-B for Alzheimer’s Disease:In January 2022, we initiated enrollment in a 48-patient, 4-arm, parallel design, randomized (1:1:1:1) Phase 2a clinical trial of Lomecel-B infusion in patients with mild Alzheimer’s disease. The Phase 2a study is intended to evaluate the safety of single and multiple infusions of two different dose levels of Lomecel-B compared to placebo. Other endpoints include...

Progressive Care Inc. Has Scheduled an Investor Conference Call for 4:30 PM ET on Tuesday, May 17, 2022 MIAMI, FL, May 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call for 4:30 PM ET on Tuesday, May 17, 2022. See on website Chairman and CEO, Alan Jay Weisberg, stated, “We are looking forward to providing our shareholders with our first quarter results, Company’s vision for the rest of 2022, and an update regarding our progress towards uplisting to Nasdaq.” Those attending the investor conference call will have the opportunity to submit questions concerning the Company in advance to Stuart Smith of SmallCapVoice.Com, Inc....

Announced oral presentation of TPST-1120 Phase 1 monotherapy and combination therapy data at ASCO Presented positive preclinical data for TPST-1495 at AACR Presented positive preclinical data with proprietary small molecule TREX1 inhibitors at AACRSOUTH SAN FRANCISCO, Calif., May 13, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted and immune-mediated mechanisms, today reported financial results for the quarter ended March 31, 2022 and provided a corporate update. “The team continued to execute well throughout the first quarter of this year, enabling us to present the first clinical data from a Tempest program at the ASCO Annual Meeting in June,” said Stephen R. Brady, chief executive officer of Tempest. “We...

BILLERICA, Mass., May 13, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL; SQLLW), a technology company providing life sciences instrumentation and research services in collaborative partnerships aimed at the development of novel scientific assets and intellectual property, today announced its operating and financial results for the first quarter ended March 31, 2021, and provided a corporate update. “We continue rapidly with our progress across multiple developmental programs around novel asset creation using SeqLL’s tSMS® platform,” said Daniel Jones, CEO, President, and Co-Founder of SeqLL. “Our team is focused on developing improved genetic tools for researchers, so they can better understand and detect the molecular mechanisms of disease which are essential for the continued development of new breakthroughs...

DALLAS, May 13, 2022 (GLOBE NEWSWIRE) — Applied Blockchain, Inc. (Nasdaq: APLD) (“Applied Blockchain” or the “Company”) today reported financial results for the fiscal third quarter ended February 28, 2022 and provided an operational update. Recent Operational and Financial HighlightsOperationalized first Next-Gen co-located datacenter in Jamestown, North Dakota in February 2022 at 55 megawatts (“MW”) currently operating just over 80MW, with remaining 20MW to come online in the next few weeks Formed joint venture (“JV”) with Antpool, an affiliate of Bitmain, in January 2022 for up to 1.5 gigawatts (“GW”) initially of co-hosting infrastructure with Applied Blockchain owning 80% of the JV Completed an initial public offering (“IPO”) with uplisting to Nasdaq in April, raising approximate net proceeds of...

Revenue growth of 62% / Total Gross Margin 26.4% NEW YORK, May 13, 2022 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its preliminary unaudited financial results for the fiscal year ended December 31, 2021, prepared in accordance with U.S. GAAP. Due to additional time required to complete its year-end reporting process, the Company determined that it was unable to file its Annual Report on Form 20-F for the fiscal year ended December 31, 2021, within the prescribed time period without unreasonable effort and expense. The Company filed a Notification of Late Filing on Form 12b-25 with the U.S. Securities and Exchange Commission on April 28, 2022. The Company is working diligently and expeditiously to complete the financial review...